Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase.

Antimicrobial Agents and Chemotherapy
D ZhangR T D'Aquila

Abstract

A human immunodeficiency virus type 1 variant resistant to zalcitabine (2',3'-dideoxycytidine [ddC]) was selected by sequential passage in the presence of increasing concentrations of ddC in peripheral blood mononuclear cell cultures. A mutation causing a lysine-to-arginine substitution was noted in reverse transcriptase (RT) codon 65 of this ddC-selected virus. A cloned mutant virus with this codon 65 mutation was constructed by using a novel PCR approach for site-directed mutagenesis. Characterization of this virus confirmed that the RT Lys-65-->Arg substitution was necessary and sufficient for a fourfold increase in the ddC 50% inhibitory concentration, as well as for resistance to didanosine (2',3'-dideoxyinosine [ddI]). Lys-65-->Arg and virus resistance to ddC and ddI also developed during therapy in isolates from one ddC-treated patient and two ddI-treated patients. Recombinant-expressed codon 65 mutant RT enzyme was resistant to ddCTP and ddATP in cell-free polymerase assays. Results of mutant enzyme studies are consistent with Lys-65-->Arg leading to changes in binding of the triphosphate forms of these nucleoside analogs to the RT. These data have implications for future studies of ddC resistance, particularly those ai...Continue Reading

References

Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·P KellamB A Larder
Nov 1, 1992·PCR Methods and Applications·A RashtchianG Heidecker
Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D RichmanJ Griffin
Jul 11, 1990·Nucleic Acids Research·J L CasanovaP Kourilsky
Jan 1, 1987·AIDS Research and Human Retroviruses·L RatnerF Wong-Staal
Jul 1, 1988·Journal of Clinical Microbiology·J B JacksonH H Balfour
Apr 1, 1993·Antimicrobial Agents and Chemotherapy·R F SchinaziJ W Mellors
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J L MartinP A Furman

❮ Previous
Next ❯

Citations

Nov 30, 2000·Current Infectious Disease Reports·G J Hanna, R T D'Aquila
Apr 1, 1995·Antiviral Research·D W KimberlinR J Whitley
May 1, 1995·Clinical and Diagnostic Virology·R T D'Aquila
Aug 1, 1994·Current Opinion in Biotechnology·W A Beard, S H Wilson
Jun 9, 2001·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·J G García-Lerma, W Heneine
Oct 25, 2003·Antimicrobial Agents and Chemotherapy·Katharina WolfBarbara Schmidt
Apr 28, 2005·Antimicrobial Agents and Chemotherapy·Anne-Geneviève MarcelinUNKNOWN AI454-176 Jaguar Study Team
Apr 5, 2002·Clinical Microbiology Reviews·Robert W Shafer
Mar 8, 2005·Journal of Clinical Microbiology·Jan WeberMiguel E Quiñones-Mateu
Apr 1, 2011·Future Microbiology·Shiro Ibe, Wataru Sugiura
Mar 4, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Sophie CapdepontUNKNOWN GECSA
Aug 16, 2000·The Journal of Infection·A S Omrani, D Pillay
Apr 1, 1997·Dermatologic Clinics·M N Chaudry, D H Shepp
Jun 5, 2010·Viruses·Antonio J Acosta-Hoyos, Walter A Scott
Jun 5, 2007·Antiviral Chemistry & Chemotherapy·Fernando A FrankelMark A Wainberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.